Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)
Egypt · Delayed Price · Currency is EGP 1,258.26
-44.89 (-3.44%)
At close: Oct 22, 2026
EGX:AXPH Revenue
In the fiscal year ending June 30, 2026, Alexandria Co. For Pharmaceuticals & Chemical Industries had annual revenue of 3.18B EGP with 15.24% growth. Alexandria Co. For Pharmaceuticals & Chemical Industries had revenue of 582.64M in the quarter ending June 30, 2026, with 10.19% growth. That makes Alexandria Co. For Pharmaceuticals & Chemical Industries the 26,876th largest company in the world by revenue and 85th in Egypt.
Revenue
3.18B
Revenue Growth
+15.24%
P/S Ratio
1.98
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.29B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 3.18B | 420.76M | 15.24% |
| Jun 30, 2025 | 2.76B | 993.68M | 56.20% |
| Jun 30, 2024 | 1.77B | 283.76M | 19.12% |
| Jun 30, 2023 | 1.48B | 384.31M | 34.94% |
| Jun 30, 2022 | 1.10B | -4.24M | -0.38% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.